Log In
Print this Print this

PDE-9 inhibitor, PDE9i

  Manage Alerts
Collapse Summary General Information
Company Pfizer Inc.
DescriptionPhosphodiesterase-9 inhibitor
Molecular Target Phosphodiesterase-9 (PDE-9)
Mechanism of Action 
Therapeutic Modality 
Latest Stage of DevelopmentPhase I
Standard IndicationSickle cell disease
Indication DetailsTreat sickle cell disease
Regulatory Designation

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today